1. Home
  2. FRT vs PRAX Comparison

FRT vs PRAX Comparison

Compare FRT & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Federal Realty Investment Trust

FRT

Federal Realty Investment Trust

HOLD

Current Price

$106.08

Market Cap

8.8B

Sector

Real Estate

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$319.22

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRT
PRAX
Founded
1962
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.6B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FRT
PRAX
Price
$106.08
$319.22
Analyst Decision
Buy
Strong Buy
Analyst Count
14
15
Target Price
$110.14
$516.93
AVG Volume (30 Days)
798.3K
568.9K
Earning Date
02-12-2026
02-27-2026
Dividend Yield
4.27%
N/A
EPS Growth
14.84
N/A
EPS
3.95
N/A
Revenue
$1,257,396,000.00
$7,463,000.00
Revenue This Year
$6.00
N/A
Revenue Next Year
$5.48
$29,535.93
P/E Ratio
$26.81
N/A
Revenue Growth
6.11
364.98
52 Week Low
$80.65
$26.70
52 Week High
$111.82
$326.91

Technical Indicators

Market Signals
Indicator
FRT
PRAX
Relative Strength Index (RSI) 69.22 60.07
Support Level $99.70 $288.57
Resistance Level $106.17 $325.22
Average True Range (ATR) 1.71 17.60
MACD 0.45 -1.62
Stochastic Oscillator 98.76 76.87

Price Performance

Historical Comparison
FRT
PRAX

About FRT Federal Realty Investment Trust

Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 102 properties, which includes 27.4 million square feet of retail space and 3,000 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

Share on Social Networks: